Literature DB >> 9391162

Unique allosteric regulation of 5-hydroxytryptamine receptor-mediated signal transduction by oleamide.

E A Thomas1, M J Carson, M J Neal, J G Sutcliffe.   

Abstract

The effects of oleamide, an amidated lipid isolated from the cerebrospinal fluid of sleep-deprived cats, on serotonin receptor-mediated responses were investigated in cultured mammalian cells. In rat P11 cells, which endogenously express the 5-hydroxytryptamine2A (5HT2A) receptor, oleamide significantly potentiated 5HT-induced phosphoinositide hydrolysis. In HeLa cells expressing the 5HT7 receptor subtype, oleamide caused a concentration-dependent increase in cAMP accumulation but with lower efficacy than that observed by 5HT. This effect was not observed in untransfected HeLa cells. Clozapine did not prevent the increase in cAMP elicited by oleamide, and ketanserin caused an approximately 65% decrease. In the presence of 5HT, oleamide had the opposite effect on cAMP, causing insurmountable antagonism of the concentration-effect curve to 5HT, but had no effect on cAMP levels elicited by isoproterenol or forskolin. These results indicate that oleamide can modulate 5HT-mediated signal transduction at different subtypes of mammalian 5HT receptors. Additionally, our data indicate that oleamide acts at an apparent allosteric site on the 5HT7 receptor and elicits functional responses via activation of this site. This represents a unique mechanism of activation for 5HT G protein-coupled receptors and suggests that G protein-coupled neurotransmitter receptors may act like their iontropic counterparts (i.e., gamma-aminobutyric acid type A receptors) in that there may be several binding sites on the receptor that regulate functional activity with varying efficacies.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9391162      PMCID: PMC28442          DOI: 10.1073/pnas.94.25.14115

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  31 in total

Review 1.  Allosteric antagonists of the muscarinic acetylcholine receptor.

Authors:  N H Lee; E E el-Fakahany
Journal:  Biochem Pharmacol       Date:  1991-07-05       Impact factor: 5.858

2.  Identification of allosteric antagonists of receptor-guanine nucleotide-binding protein interactions.

Authors:  R R Huang; R N Dehaven; A H Cheung; R E Diehl; R A Dixon; C D Strader
Journal:  Mol Pharmacol       Date:  1990-02       Impact factor: 4.436

3.  Interactions of amiloride with alpha- and beta-adrenergic receptors: amiloride reveals an allosteric site on alpha 2-adrenergic receptors.

Authors:  M J Howard; R J Hughes; H J Motulsky; M D Mullen; P A Insel
Journal:  Mol Pharmacol       Date:  1987-07       Impact factor: 4.436

4.  Allosteric properties of the 5-HT2 receptor system of the rat tail artery. Ritanserin and methysergide are not competitive 5-HT2 receptor antagonists but allosteric modulators.

Authors:  M Frenken; A J Kaumann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-04       Impact factor: 3.000

Review 5.  Allosteric modulatory centers of transmitter amino acid receptors.

Authors:  E Costa
Journal:  Neuropsychopharmacology       Date:  1989-09       Impact factor: 7.853

6.  Identification of fatty acid amides in human plasma.

Authors:  E S Arafat; J W Trimble; R N Andersen; C Dass; D M Desiderio
Journal:  Life Sci       Date:  1989       Impact factor: 5.037

7.  Brain lipids that induce sleep are novel modulators of 5-hydroxytrypamine receptors.

Authors:  J P Huidobro-Toro; R A Harris
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-23       Impact factor: 11.205

8.  Evidence for allosteric blockade of serotonergic receptors in rabbit thoracic aorta.

Authors:  Z Xu; R E Purdy
Journal:  J Pharmacol Exp Ther       Date:  1989-03       Impact factor: 4.030

9.  Glycine-directed peptide amidation: presence in rat brain of two enzymes that convert p-Glu-His-Pro-Gly-OH into p-Glu-His-Pro-NH2 (thyrotropin-releasing hormone).

Authors:  J S Kizer; W H Busby; C Cottle; W W Youngblood
Journal:  Proc Natl Acad Sci U S A       Date:  1984-05       Impact factor: 11.205

10.  Heparin uncouples alpha 2-adrenoceptors from the Gi-protein in membranes of human platelets.

Authors:  B Willuweit; K Aktories
Journal:  Biochem J       Date:  1988-02-01       Impact factor: 3.857

View more
  24 in total

1.  Allosteric modulation of seven transmembrane spanning receptors: theory, practice, and opportunities for central nervous system drug discovery.

Authors:  Bruce J Melancon; Corey R Hopkins; Michael R Wood; Kyle A Emmitte; Colleen M Niswender; Arthur Christopoulos; P Jeffrey Conn; Craig W Lindsley
Journal:  J Med Chem       Date:  2012-01-06       Impact factor: 7.446

Review 2.  [Cannabinoids--signal transduction and mode of action].

Authors:  R Rukwied; B Gauter; M Schley; C Konrad
Journal:  Schmerz       Date:  2005-11       Impact factor: 1.107

3.  Skeletal muscle interstitial fluid metabolomics at rest and associated with an exercise bout: application in rats and humans.

Authors:  Jie Zhang; Sudeepa Bhattacharyya; Robert C Hickner; Alan R Light; Christopher J Lambert; Bruce K Gale; Oliver Fiehn; Sean H Adams
Journal:  Am J Physiol Endocrinol Metab       Date:  2018-11-06       Impact factor: 4.310

4.  Allosteric modulation of A(3) adenosine receptors by a series of 3-(2-pyridinyl)isoquinoline derivatives.

Authors:  Z G Gao; J E Van Muijlwijk-Koezen; A Chen; C E Müller; A P Ijzerman; K A Jacobson
Journal:  Mol Pharmacol       Date:  2001-11       Impact factor: 4.436

Review 5.  The complications of promiscuity: endocannabinoid action and metabolism.

Authors:  S P H Alexander; D A Kendall
Journal:  Br J Pharmacol       Date:  2007-09-17       Impact factor: 8.739

Review 6.  Biosynthesis, degradation and pharmacological importance of the fatty acid amides.

Authors:  Emma K Farrell; David J Merkler
Journal:  Drug Discov Today       Date:  2008-04-03       Impact factor: 7.851

Review 7.  Allosteric modulators of g protein-coupled receptors: future therapeutics for complex physiological disorders.

Authors:  Liyun Wang; Bronwen Martin; Randall Brenneman; Louis M Luttrell; Stuart Maudsley
Journal:  J Pharmacol Exp Ther       Date:  2009-08-10       Impact factor: 4.030

8.  Chemical requirements for inhibition of gap junction communication by the biologically active lipid oleamide.

Authors:  D L Boger; J E Patterson; X Guan; B F Cravatt; R A Lerner; N B Gilula
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-28       Impact factor: 11.205

9.  Exceptionally potent inhibitors of fatty acid amide hydrolase: the enzyme responsible for degradation of endogenous oleamide and anandamide.

Authors:  D L Boger; H Sato; A E Lerner; M P Hedrick; R A Fecik; H Miyauchi; G D Wilkie; B J Austin; M P Patricelli; B F Cravatt
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-09       Impact factor: 11.205

10.  Inhibition of ligand binding to G protein-coupled receptors by arachidonic acid.

Authors:  Elizabeth Z Bordayo; John R Fawcett; Sarita Lagalwar; Aleta L Svitak; William H Frey
Journal:  J Mol Neurosci       Date:  2005       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.